123 related articles for article (PubMed ID: 2859169)
1. Quantitative account of propranolol metabolism in urine of normal man.
Walle T; Walle UK; Olanoff LS
Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
[TBL] [Abstract][Full Text] [Related]
2. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
Walle T; Wilson MJ; Walle UK; Bai SA
Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
[TBL] [Abstract][Full Text] [Related]
3. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
4. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
[TBL] [Abstract][Full Text] [Related]
5. Influence of aging on the oxidative and conjugative metabolism of propranolol.
Tateishi T; Fujimura A; Shiga T; Ohashi K; Ebihara A
Int J Clin Pharmacol Res; 1995; 15(3):95-101. PubMed ID: 8847155
[TBL] [Abstract][Full Text] [Related]
6. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques.
Bargar EM; Walle UK; Bai SA; Walle T
Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective ring oxidation of propranolol in man.
Walle T; Walle UK; Wilson MJ; Fagan TC; Gaffney TE
Br J Clin Pharmacol; 1984 Nov; 18(5):741-8. PubMed ID: 6508983
[TBL] [Abstract][Full Text] [Related]
9. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
[TBL] [Abstract][Full Text] [Related]
10. The influence of diltiazem versus cimetidine on propranolol metabolism.
Tateishi T; Ohashi K; Fujimura A; Ebihara A
J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
[TBL] [Abstract][Full Text] [Related]
11. Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites.
Bai SA; Walle T
Drug Metab Dispos; 1984; 12(6):749-54. PubMed ID: 6150825
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
[TBL] [Abstract][Full Text] [Related]
13. Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx).
Stillwell WG; Turesky RJ; Gross GA; Skipper PL; Tannenbaum SR
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):399-405. PubMed ID: 7920207
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
16. O-methylated catechol-like metabolites of propranolol in man.
Walle T; Conradi EC; Walle UK; Gaffney TE
Drug Metab Dispos; 1978; 6(4):481-7. PubMed ID: 28930
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
18. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog.
Bai SA; Easterling DE; Wilson MJ; Walle UK; Haney CA; Peet NP; Pruett JK; Walle T
Drug Metab Dispos; 1989; 17(5):495-505. PubMed ID: 2573492
[TBL] [Abstract][Full Text] [Related]
20. Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.
Ring JA; Ghabrial H; Ching MS; Shulkes A; Smallwood RA; Morgan DJ
Drug Metab Dispos; 1995 Feb; 23(2):190-6. PubMed ID: 7736910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
